Biotech Startups

Aclid provides an automation platform for biosecurity and biosafety compliance, offering real-time screening that generates threat assessments and risk profiles for genes, libraries, pools, viral vectors, and plasmids. It also automates verification of licenses, registrations, biosafety guidelines, and legitimate use for research organizations.

3 investors

Acoustica.bio develops acoustophoretic technology and microgel suspension formulations that concentrate biologic drugs (such as monoclonal antibodies) to ultra-high concentrations exceeding 500 mg/mL for small-volume subcutaneous injection. It serves drug developers, aiming to convert hospital-based intravenous therapies into patient-friendly at-home injections in the biotech/drug delivery space.

3 investors

Actio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions. It focuses on identifying dysregulated gene activity and designing therapies to restore balance and address the root causes of disease.

3 investors

A biopharmaceutical company with over 30 years of experience developing and commercializing treatments for central nervous system (CNS) diseases. It maintains a pipeline of product candidates supported by internal research and development.

3 investors

Aphage develops AI and sensor technologies to identify, track, and classify physical threats across borders, infrastructure, and transportation networks for government and security organizations.

3 investors

Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology. It develops site-specific ADC therapeutics and supporting platform technology for cancer treatment.

3 investors

Addimmune develops gene therapy treatments for HIV, specifically AGT103-T, a first-in-class functional cure candidate that modifies patient immune cells to recognize and eliminate HIV-infected cells. The company is based in Rockville, Maryland and targets individuals living with HIV.

3 investors

Addition Therapeutics is a biotechnology company developing therapeutics, led by a scientific and clinical team. Its work centers on drug discovery and portfolio development in the life sciences.

3 investors

Adela develops blood-based tests for cancer detection using epigenetics and liquid biopsy technology, aimed at helping patients and clinicians detect and act on cancer earlier. It serves the oncology and cancer care market.

3 investors

Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation. The device is FDA-cleared for below-the-knee use and enables localized infusion of various physician-prescribed medications to prevent restenosis after vessel modification procedures.

3 investors

Afynia develops diagnostic tools focused on women's health, with an emphasis on endometriosis detection through diagnostic biomarkers. The company operates a CLIA laboratory and works on molecular biology testing for reproductive health conditions.

3 investors

Again is an AI-native biomanufacturing platform that uses computational biology and proprietary biological data to design molecules for chemicals, materials, agriculture, and food production, replacing traditional petrochemical manufacturing methods.

3 investors

AgGene develops plant traits using genome editing for agricultural improvement. The company serves grain farmers and the seed industry by combining biotechnology with practical farming expertise.

3 investors

Agile Therapeutics develops and markets contraceptive and women's health products using its proprietary Skinfusion® transdermal technology platform. The company focuses on providing healthcare options for women through innovative delivery mechanisms.

3 investors

Agragene develops Precision-Guided Sterile Insect Technology (pgSIT) marketed as KNOCKOUT™, a biocontrol product for controlling crop insect pests such as Spotted Wing Drosophila while reducing reliance on traditional insecticides. It serves agricultural growers of berries and cherries in the US and Canada, working alongside integrated pest management programs.

3 investors

AGRITX develops nutritional products for avian embryonic development to improve poultry farming outcomes. The company focuses on enhancing animal welfare and farm profitability while reducing environmental impact in the global poultry industry.

3 investors

Agrivida develops enzyme technology for animal feed and nutrition, improving efficiency in poultry, swine, and other livestock production. The company applies biochemical research to create solutions that enhance sustainable food production.

3 investors

AgroSpheres develops biodegradable encapsulation technology using biomolecules and plant extracts to create crop protection and plant health products for farmers, targeting specific pests while protecting pollinators. Its products aim to replace conventional chemicals and microplastics in agriculture, with a fermentation-based manufacturing process that produces and encapsulates active ingredients in one step.

3 investors

AIM Biotech develops organ-on-chip and 3D tissue culture platforms (idenTx, organiX, and Avatar) for drug discovery and preclinical research. The company provides tools for academic and pharmaceutical researchers to model human tissue microenvironments and accelerate therapeutic development.

3 investors

Aiolos Bio is a biopharma company that discovers, develops, and delivers medicines and vaccines across respiratory, immunology, inflammation, oncology, HIV, and infectious diseases.

3 investors

Airfinity provides AI-powered predictive analytics, simulation, and forecasting for the life sciences industry, focused on medicine and vaccine demand forecasting across specific disease areas. It serves biopharma companies, governments, and global health organisations to support decision-making.

3 investors

Aitia builds in silico models of human disease biology using a causal AI platform that combines multiomic and clinical patient data with supercomputing to support drug discovery and development. It partners with biopharma companies to identify novel drug targets across diseases such as oncological, neurodegenerative, immunological, and cardiometabolic conditions.

3 investors

Quanterix (operating together with Akoya) develops biomarker measurement platforms that combine ultrasensitive blood/CSF liquid immunoassays with spatial tissue proteomics for research and clinical use in neurology, oncology, inflammation, cardiology and infectious disease. It serves pharmaceutical companies, CROs, diagnostics labs and academic researchers, offering CLIA-ready assays and spatial biology panels.

3 investors

Akston Biosciences develops protein-based therapies for pets to support veterinary care and improve treatment accessibility. The company focuses on pet-focused biotechnology aimed at making animal therapies more affordable for pet owners.

3 investors